missing translation for 'onlineSavingsMsg'
Få mere at vide

Rebastinib, MedChemExpress

Artikelnummer. 16448207
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
10 mg
50 mg
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
16448207 5 mg
16461667 50 mg
16405498 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 16448207 Leverandør Medchem Express Leverandørnr. HY13024

Please to purchase this item. Need a web account? Register with us today!

Denne vare kan ikke returneres. Se returpolicy

MedChemExpress Rebastinib (DCC-2036) is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit.

Rebastinib (DCC-2036) is an orally active, non-ATP-competitive Bcr-Abl inhibitor for Abl1WT and Abl1T315I with IC50s of 0.8 nM and 4 nM, respectively. Rebastinib also inhibits SRC, KDR, FLT3, and Tie-2, and has low activity to seen towards c-Kit.

Specifications

Kemisk navn eller materiale Rebastinib
CAS 1020172-07-9
Farve Off-White
Renhedsgrad noter Research
Molekylær formel C30H28FN7O3
Mængde 5 mg
Synonym DCC-2036
Opløselighedsinformation DMSO : 50 mg/mL (90.32 mM; ultrasonic and warming and heat to 80°C)
SMIL CC(C)(C)C1=NN(C(NC(NC2=C(F)C=C(OC3=CC(C(NC)=O)=NC=C3)C=C2)=O)=C1)C4=CC=C5C(C=CC=N5)=C4
Molekylvægt (g/mol) 553.59
Formel vægt 553.59
Procent renhed 98.0%
Grad Research
Fysisk form Powder
Til brug med (applikation) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.